Table 3.
Duration in target segment during probe trial (sec) | |||||
---|---|---|---|---|---|
Day | Treatment | Mean | SE | F value | P value |
5 |
G.biloba
50 mg/kg |
20.5938462 |
3.44090282 |
(7,100) = 4.2333 |
p = 0.0004*** |
5 |
P.minus
50 mg/kg |
18.3257143 |
3.70012143 |
(7,105) = 1.7621 |
p = 0.1036 n.s |
5 |
P.minus
100 mg/kg |
19.7230769 |
2.53861445 |
(7,95) = 6.6852 |
p = 0.0015** |
5 |
Donepezil 1 mg/kg |
16.6314286 |
1.65977983 |
(7,111) = 6.9417 |
p < 0.0001*** |
5 |
Veh/Sco |
16.5533333 |
2.48504781 |
(7,88) = 1.7926 |
p = 0.0999 n.s |
5 | Veh/Veh | 19.7384615 | 1.69910151 | (7,103) = 6.8633 | p < 0.0001*** |
***, One-way ANOVA demonstrated significant duration in the target segment p < 0.0001.
**, One-way ANOVA demonstrated significant duration in the target segment p < 0.001.
n.s, non significant.